BioCorRx (BICX) Gross Profit (2016 - 2025)
BioCorRx (BICX) has disclosed Gross Profit for 15 consecutive years, with $134899.0 as the latest value for Q1 2025.
- Quarterly Gross Profit rose 6807.27% to $134899.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $138944.0 through Mar 2025, up 494.77% year-over-year, with the annual reading at $5998.0 for FY2024, 88.72% down from the prior year.
- Gross Profit hit $134899.0 in Q1 2025 for BioCorRx, up from $4045.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $134899.0 in Q1 2025 to a low of $1953.0 in Q1 2024.
- Historically, Gross Profit has averaged $29001.6 across 5 years, with a median of $11182.0 in 2021.
- Biggest five-year swings in Gross Profit: crashed 93.85% in 2024 and later skyrocketed 6807.27% in 2025.
- Year by year, Gross Profit stood at $11182.0 in 2021, then soared by 563.6% to $74204.0 in 2022, then crashed by 92.07% to $5885.0 in 2023, then tumbled by 31.27% to $4045.0 in 2024, then skyrocketed by 3234.96% to $134899.0 in 2025.
- Business Quant data shows Gross Profit for BICX at $134899.0 in Q1 2025, $4045.0 in Q2 2024, and $1953.0 in Q1 2024.